Valproate decreases frequency facilitation at mossy fiber--CA3 synapses after status epilepticus

Pishan Chang1, Matthew C Walker

  • 1UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.

Epilepsy Research
|December 21, 2010
PubMed

Insights

Valproate specifically impacts short-term synaptic plasticity in the epileptic brain, not in healthy controls. This suggests targeted therapeutic actions of valproate in epilepsy.

Area of Science:

  • Neuroscience
  • Epilepsy Research
  • Synaptic Plasticity

Background:

  • Mossy fiber to CA3 synapses are crucial for memory and exhibit metaplasticity during epilepsy development.
  • Valproate is known to modulate long-term plasticity in healthy brain tissue.

Purpose of the Study:

  • To investigate the specific effects of valproate on synaptic plasticity in the context of epilepsy.
  • To determine if valproate's actions differ between healthy and epileptic brain tissue.

Main Methods:

  • Electrophysiological recordings were performed on hippocampal slices.
  • Frequency facilitation (a form of short-term plasticity) was measured at mossy fiber to CA3 synapses.
  • Experiments were conducted on slices from both control animals and animals post-status epilepticus.

Main Results:

  • Valproate significantly altered frequency facilitation at mossy fiber to CA3 synapses in slices from post-status epilepticus animals.
  • Valproate did not alter frequency facilitation in slices from control animals.
  • These findings highlight a differential effect of valproate based on the brain's epileptic state.

Conclusions:

  • Valproate exhibits specific actions on short-term synaptic plasticity within the epileptic brain.
  • This suggests that valproate may have targeted therapeutic mechanisms in epilepsy that differ from its effects in healthy brains.

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...